erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Respiratory Insufficiency D012131 10 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Nephritis, Interstitial D009395 10 associated lipids
Ischemia D007511 18 associated lipids
Epilepsy D004827 35 associated lipids
Seizures D012640 87 associated lipids
Cat-Scratch Disease D002372 4 associated lipids
Birth Weight D001724 23 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Thromboembolism D013923 6 associated lipids
Periodontitis D010518 22 associated lipids
Dermatitis D003872 30 associated lipids
Nasal Polyps D009298 26 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Vomiting D014839 21 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Streptococcal Infections D013290 4 associated lipids
Otitis D010031 5 associated lipids
Cholelithiasis D002769 16 associated lipids
Fever D005334 35 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Pneumonia D011014 10 associated lipids
Conjunctivitis D003231 7 associated lipids
Syphilis D013587 6 associated lipids
Chorioamnionitis D002821 5 associated lipids
Obstetric Labor, Premature D007752 9 associated lipids
Hearing Disorders D006311 10 associated lipids
Duodenitis D004382 4 associated lipids
Death, Sudden D003645 12 associated lipids
Cardiomegaly D006332 31 associated lipids
Tachycardia D013610 7 associated lipids
Common Cold D003139 2 associated lipids
Hemoglobin SC Disease D006450 2 associated lipids
Foot Diseases D005534 4 associated lipids
Leukemia, Lymphoid D007945 18 associated lipids
Neutropenia D009503 15 associated lipids
Aortic Valve Stenosis D001024 4 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Urticaria D014581 13 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Leishmaniasis D007896 19 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
HIV Seropositivity D006679 15 associated lipids
Uveitis D014605 14 associated lipids
Surgical Wound Dehiscence D013529 3 associated lipids
Endophthalmitis D009877 12 associated lipids
Leprosy D007918 8 associated lipids
Laryngitis D007827 5 associated lipids
Cardiac Tamponade D002305 7 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Anemia, Hypochromic D000747 5 associated lipids
Dyspnea D004417 10 associated lipids
Listeriosis D008088 12 associated lipids
Periapical Diseases D010483 4 associated lipids
Tremor D014202 15 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Pemphigoid, Bullous D010391 8 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Hypothermia D007035 19 associated lipids
Orthomyxoviridae Infections D009976 3 associated lipids
Kidney Diseases, Cystic D052177 3 associated lipids
Hypoventilation D007040 2 associated lipids
Food Hypersensitivity D005512 7 associated lipids
Paresthesia D010292 7 associated lipids
Pulmonary Emphysema D011656 3 associated lipids
Pleural Effusion D010996 3 associated lipids
Lipidoses D008064 7 associated lipids
Bronchopneumonia D001996 7 associated lipids
Pyoderma D011711 5 associated lipids
Lymphadenitis D008199 8 associated lipids
Drug Eruptions D003875 30 associated lipids
Folliculitis D005499 7 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Skin Diseases, Infectious D012874 7 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Synovitis D013585 15 associated lipids
Cleft Palate D002972 9 associated lipids
Herpes Zoster Ophthalmicus D006563 2 associated lipids
Choline Deficiency D002796 16 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Gangrene D005734 3 associated lipids
Toxoplasmosis, Animal D014124 5 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Campylobacter Infections D002169 13 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Bacteremia D016470 9 associated lipids
Arthralgia D018771 8 associated lipids
Nausea D009325 7 associated lipids
Prostatitis D011472 5 associated lipids
Factor X Deficiency D005171 2 associated lipids
Mycoplasma Infections D009175 13 associated lipids
Stomatitis D013280 14 associated lipids
Lung Diseases, Interstitial D017563 5 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Rigauts HD et al. Erythromycin-induced hepatitis: simulator of malignancy. 1988 Radiology pmid:3055031
Kearney GC et al. Structural elucidation studies of erythromycins by electrospray tandem mass spectrometry II. 1999 Rapid Commun. Mass Spectrom. pmid:10440983
Bogialli S et al. A simple and rapid confirmatory assay for analyzing antibiotic residues of the macrolide class and lincomycin in bovine milk and yoghurt: hot water extraction followed by liquid chromatography/tandem mass spectrometry. 2007 Rapid Commun. Mass Spectrom. pmid:17171776
Volmer DA and Hui JP Study of erythromycin A decomposition products in aqueous solution by solid-phase microextraction/liquid chromatography/tandem mass spectrometry. 1998 Rapid Commun. Mass Spectrom. pmid:9474800
Takahashi Y et al. Accurate mass determination by multiple sprayers nano-electrospray mass spectrometry on a magnetic sector instrument. 2000 Rapid Commun. Mass Spectrom. pmid:10844730
Bajic S et al. Analysis of erythromycin by liquid chromatography/mass spectrometry using involatile mobile phases with a novel atmospheric pressure ionization source. 2000 Rapid Commun. Mass Spectrom. pmid:10637421
Owen SJ et al. Increasing sensitivity and decreasing spot size using an inexpensive, removable hydrophobic coating for matrix-assisted laser desorption/ionisation plates. 2003 Rapid Commun. Mass Spectrom. pmid:14587091
Jackson SN et al. On-line laser desorption/ionization mass spectrometry of matrix-coated aerosols. 2004 Rapid Commun. Mass Spectrom. pmid:15378715
Govaerts C et al. Investigation of unknown related substances in commercial erythromycin samples with liquid chromatography/mass spectrometry. 2000 Rapid Commun. Mass Spectrom. pmid:10825252
Gates PJ et al. Structural elucidation studies of erythromycins by electrospray tandem mass spectrometry. 1999 Rapid Commun. Mass Spectrom. pmid:10097401
Garzotti M et al. Coupling of a supercritical fluid chromatography system to a hybrid (Q-TOF 2) mass spectrometer: on-line accurate mass measurements. 2001 Rapid Commun. Mass Spectrom. pmid:11445901
CANNAVO L [Combined antitoxin and erythromycin therapy in diphtheria in the adult]. 1955 Rass Clin Sci pmid:13290047
Biron CR Erythromycin. 1993 RDH pmid:8332759
Debbia EA [Antibiotic resistance: an always present problem]. 1999 Recenti Prog Med pmid:10592734
Utsunomiya S et al. Critical residues in the transmembrane helical bundle domains of the human motilin receptor for erythromycin binding and activity. 2013 Regul. Pept. pmid:23142315
Kitazawa T et al. Functional characterization of neural and smooth muscle motilin receptors in the chicken proventriculus and ileum. 1997 Regul. Pept. pmid:9416990
Nunoi H et al. A relationship between motilin and growth hormone secretagogue receptors. 2012 Regul. Pept. pmid:22465164
Depoortere I and Peeters TL Transduction mechanism of motilin and motilides in rabbit duodenal smooth muscle. 1995 Regul. Pept. pmid:7761622
Depoortere I et al. Effect of erythromycin and of octreotide on motilin receptor density in the rabbit. 1991 Regul. Pept. pmid:2034824
Takanashi H and Cynshi O Motilides: a long and winding road: lessons from mitemcinal (GM-611) on diabetic gastroparesis. 2009 Regul. Pept. pmid:19345243
Masclee AA et al. Effect of antrectomy and truncal vagotomy on erythromycin induced pancreatic polypeptide secretion. 1995 Regul. Pept. pmid:8577928
Carman RJ et al. Antibiotics in the human food chain: establishing no effect levels of tetracycline, neomycin, and erythromycin using a chemostat model of the human colonic microflora. 2005 Regul. Toxicol. Pharmacol. pmid:16129531
McCormack AJ et al. Primary renovascular effects of erythromycin in the rat: relationship to cyclosporine nephrotoxicity. 1990 Ren Fail pmid:2100828
Rollins G Single antibiotic therapy as effective as dual in treating patients hospitalized with community acquired pneumonia. 2000 Rep Med Guidel Outcomes Res pmid:11799995
Janowski T et al. Combined gnRH and PGF2alpha application in cows with endometritis puerperalis treated with antibiotics. 2001 Reprod. Domest. Anim. pmid:11885741
Bianca S et al. Pityriasis rosea in pregnancy. 2007 Nov-Dec Reprod. Toxicol. pmid:17604600
Czeizel AE et al. A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. 1999 Nov-Dec Reprod. Toxicol. pmid:10613401
Källén BA et al. Is erythromycin therapy teratogenic in humans? 2005 Jul-Aug Reprod. Toxicol. pmid:15907655
Melethil S et al. Steady state urinary excretion of theophylline and its metabolites in the presence of erythromycin. 1982 Res. Commun. Chem. Pathol. Pharmacol. pmid:7071419
Antignac E and Fukuhara M Identification of a constitutive form of cytochrome P-450 with high activity towards macrolide antibiotics in Syrian golden hamster liver. 1992 Res. Commun. Chem. Pathol. Pharmacol. pmid:1518960
Bachmann K et al. Single dose phenytoin clearance during erythromycin treatment. 1984 Res. Commun. Chem. Pathol. Pharmacol. pmid:6515115
Tagaya E et al. Erythromycin inhibits cholinergic neuro-effector transmission in canine airway smooth muscle. 1994 Res. Commun. Mol. Pathol. Pharmacol. pmid:7994563
Begovic J et al. Human vaginal Lactobacillus rhamnosus harbor mutation in 23S rRNA associated with erythromycin resistance. 2009 Jul-Aug Res. Microbiol. pmid:19619642
Kos VN et al. Species identification of erythromycin-resistant Campylobacter isolates and optimization of a duplex PCR for rapid detection. 2006 Jul-Aug Res. Microbiol. pmid:16500085
Yajko DM In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment? 1992 Res. Microbiol. pmid:1455069
Wang X et al. Phenotypic and molecular characterization of Streptococcus agalactiae colonized in Chinese pregnant women: predominance of ST19/III and ST17/III. Res. Microbiol. pmid:29378338
Nunez-Samudio V and Chesneau O Functional interplay between the ATP binding cassette Msr(D) protein and the membrane facilitator superfamily Mef(E) transporter for macrolide resistance in Escherichia coli. 2013 Res. Microbiol. pmid:23261969
Clarke CR et al. Distribution of intramuscularly administered erythromycin into subcutaneous tissue chambers before and after inoculation with Pasteurella haemolytica. 1993 Res. Vet. Sci. pmid:8337485
Punch PI et al. Plasma and tear concentrations of antibiotics administered parenterally to cattle. 1985 Res. Vet. Sci. pmid:4070785
Zweers-Zeilmaker WM et al. In vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle. 1999 Res. Vet. Sci. pmid:10088712
Burrows GE et al. Antipyrine, erythromycin and oxytetracycline disposition in experimental fasciolosis. 1992 Res. Vet. Sci. pmid:1439209
Dutta GN and Devriese LA Resistance to macrolide-lincosamide-streptogramin antibiotics in enterococci from the intestines of animals. 1982 Res. Vet. Sci. pmid:6813931
Baggot JD and Gingerich DA Pharmacokinetic interpretation of erythromycin and tylosin activity in serum after intravenous administration of a single dose to cows. 1976 Res. Vet. Sci. pmid:1030820
Bech-Nielsen GV et al. Manipulation of the gut microbiota in C57BL/6 mice changes glucose tolerance without affecting weight development and gut mucosal immunity. 2012 Res. Vet. Sci. pmid:21543097
Lewis J and Poland J Sensitivity of mycoplasmas of the respiratory tract of pigs and horses to erythromycin and its use in selective media. 1978 Res. Vet. Sci. pmid:564541
Kamio K and Azuma A Diffuse panbronchiolitis: A fine road from the discovery of a disease to the establishment of treatment. 2018 Respir Investig pmid:30049592
Mishra RK et al. Diffuse panbronchiolitis research in MEDLINE (1969-2017): Report of a bibliometric analysis. 2018 Respir Investig pmid:30008294
The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. The British Thoracic Society Research Committee and The Public Health Laboratory Service. 1992 Respir Med pmid:1565823
Haworth CS et al. Long-term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions. 2014 Respir Med pmid:25301290
Tredaniel J et al. Diffuse panbronchiolitis: efficacy of low-dose erythromycin. 1993 Respir Med pmid:8497706
Tang CM and Macfarlane JT Early management of younger adults dying of community acquired pneumonia. 1993 Respir Med pmid:9728229
Jolley AE et al. Audit of the use of erythromycin in the treatment of community-acquired lower respiratory infections. 1992 Respir Med pmid:1470708
Lin HC et al. Erythromycin inhibits beta2-integrins (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils. 2000 Respir Med pmid:10926336
Ishiura Y et al. Additive effect of continuous low-dose ofloxacin on erythromycin therapy for sinobronchial syndrome. 1995 Respir Med pmid:8570882
Serisier DJ and Martin ML Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations. 2011 Respir Med pmid:21367595
Simoens S et al. Preventing COPD exacerbations with macrolides: a review and budget impact analysis. 2013 Respir Med pmid:23352223
Trédaniel J et al. Diffuse panbronchiolitis: efficacy of low-dose erythromycin. 1994 Respir Med pmid:7938804
Lin CC et al. Effect of erythromycin on bronchial hyperreactivity and inflammation in ovalbumin-sensitized brown Norway rats. 2008 Respir Physiol Neurobiol pmid:18430615
She J et al. Association of HLA genes with diffuse panbronchiolitis in Chinese patients. 2007 Respir Physiol Neurobiol pmid:17350353
Li YJ et al. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts. 2006 Respir. Res. pmid:16438734
He ZY et al. Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease. 2010 Respiration pmid:20881376
Leroyer C et al. Dirithromycin concentrations in bronchial mucosa and secretions. 1998 Respiration pmid:9782221
Duranti R Long-term treatment with macrolides - light in the darkness of COPD therapy? 2010 Respiration pmid:21079411
Morikawa T et al. Superoxide dismutase in alveolar macrophages from patients with diffuse panbronchiolitis. 2000 Respiration pmid:11070461
He Z et al. Suppression of oxidant-induced glutathione synthesis by erythromycin in human bronchial epithelial cells. 2008 Respiration pmid:18032881
Susanto CR et al. Nonresolving pneumonia in mycoplasma pneumoniae infection resembling a lung tumor. 2006 Respiration pmid:16131788
Leuenberger P et al. Mycobacterium malmoense--report of a case in Switzerland. 1987 Respiration pmid:3659578
Mizukane R et al. An elderly patient with hemophagocytic syndrome due to severe mycoplasma pneumonia with marked hypercytokinemia. 2002 Respiration pmid:11844970
Pacheco A et al. Community acquired pneumonia caused by Chlamydia pneumoniae strain TWAR in chronic cardiopulmonary disease in the elderly. 1991 Respiration pmid:1792424
Mitsuyama T et al. Inhibition by erythromycin of superoxide anion production by human polymorphonuclear leukocytes through the action of cyclic AMP-dependent protein kinase. 1995 Respiration pmid:8560094
Nagai H et al. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. 1991 Respiration pmid:1745845
Shibuya Y et al. The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum. 2001 Respiration pmid:11786718
Gump DW and Hawley HB Severe Mycoplasma pneumoniae pneumonia. 1976 Respiration pmid:1005941
Mitsuyama T et al. Inhibition by erythromycin of human pulmonary artery endothelial cell injury induced by human neutrophils. 1997 Respiration pmid:9154672
Nayci A et al. Gut decontamination prevents bronchoscopy-induced bacterial translocation. An experimental study in rats. 2004 Jan-Feb Respiration pmid:14872113
Xie C et al. The effects of erythromycin on the viability and the secretion of TNF-alpha and TGF-beta1 and expression of connexin43 by human pleural mesothelial cells. 2005 Respirology pmid:16268908
Inoue D et al. Erythromycin attenuates MUC5AC synthesis and secretion in cultured human tracheal cells infected with RV14. 2008 Respirology pmid:18339018
Fujimura M et al. Addition of a 2-month low-dose course of levofloxacin to long-term erythromycin therapy in sinobronchial syndrome. 2002 Respirology pmid:12421239
Chen B et al. Ameliorating effect of erythromycin on bleomycin-induced pulmonary fibrosis: role of alveolar macrophage activation and cytokine release. 1997 Respirology pmid:9441129
Turley AJ et al. Acute myocarditis secondary to Campylobacter jejuni enterocolitis. 2008 Resuscitation pmid:18617316
O'Halloran HS et al. Leber's neuroretinitis in a patient with serologic evidence of Bartonella elizabethae. 1998 Retina (Philadelphia, Pa.) pmid:9654422
Canzano JC and Lim JI Pars plana vitrectomy for epiretinal membrane secondary to cat scratch neuroretinitis. 2001 Retina (Philadelphia, Pa.) pmid:11421023
Sroczyński K et al. [Clinical and bacteriological investigations in upper respiratory tract infections in children. II. Comparison of the results of therapy with penicillin and erythromycin in the light of clinical and bacteriological studies]. 1970 Reumatologia pmid:5199553
Meiss A and Caride ER [Evaluation of the efficiency of metronidazole as chemotherapy for acute pericoronitis]. 1982 Mar-Apr Rev Asoc Odontol Argent pmid:6763727
Pinto AC [The use of erythromycin ethylsuccinate in the most common infections in pedodontics]. 1970 Jul-Aug Rev Assoc Paul Cir Dent pmid:4253383
DONEUX J and WAUTERS G [Staphylococci and antibiotics of the erythromycin group]. 1961 Rev Belg Pathol Med Exp pmid:13887208
Segal J [Clinico-paracytological and therapeutic study with a new preparation of erythromycin stearate of controlled release (A-16535) in intestinal amebiasis]. 1967 Rev Bras Med pmid:5603001
Levy A et al. [Sustained-release erythromycin sterate in the therapy of intestinal amebiasis]. 1967 Rev Bras Med pmid:5604985
de Almeida AJ [Clinico-therapeutic observations on the use of erythromycin ethylsuccinate in infections in ambulatory pediatric practice]. 1969 Rev Bras Med pmid:5347024
Campos R [Treatment of intestinal amebiasis using erythromycin stearate under controlled release]. 1969 Rev Bras Med pmid:5790651
Bialski R [Erythromycin stearate in "single dose" in the treatment of acute masculine gonococcal urethritis]. 1969 Rev Bras Med pmid:5800220
Pádua Mde A [Treatment of chronic intestinal amebiasis using non-absorbent erythromycin stearate (case study)]. 1969 Rev Bras Med pmid:5381894
Ramos e Silva J [Current treatment of syphilis, particularly of early syphilis]. 1968 Rev Bras Med pmid:5707186
Vendemiatti E [Specific action of erythromycin stearate as an amebicide]. 1969 Rev Bras Med pmid:5386029
Martinez AA and Levy A [Efficiency of the combination erythromycin-hexocylium in the treatment of dysentery syndromes]. 1969 Rev Bras Med pmid:5386032
ROCHA H [Treatment of non-gonococcal urethritis with erythromycin propionate lauryl sulfate]. 1961 Rev Bras Med pmid:14492998
Levy A et al. [Study "in vitro" and "in vivo" using erythromycin stearate in the therapy of respiratory and cutaneous infections]. 1968 Rev Bras Med pmid:5717048
Ogawa P [Contribution to the study of erythromycin combined with betaine, in controlling the most common toxi-infectious states in medical practice]. 1971 Rev Bras Med pmid:5556805
Lockhart JD Proceedings: Bioavailability of antibiotics. 1973 Rev Can Biol pmid:4777597
CLOUTIER S et al. [COMPARISON, USING 4 METHODS OF EXPERIMENTAL INFECTION, OF THE PATHOGENICITY OF 72 STRAINS OF STAPHYLOCOCCUS ISOLATED FROM THE BOVINE UDDER]. 1964 Rev Can Biol pmid:14237152